Lv11
48 积分 2023-01-10 加入
Cellular senescence is a promising target for chronic wounds: a comprehensive review
8小时前
已完结
MASLD, MASH, and the CKM Spectrum
17天前
已完结
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
23天前
已完结
Inflammation‐mediated metabolic regulation in adipose tissue
23天前
已完结
Tirzepatide for Obesity Treatment and Diabetes Prevention
27天前
已完结
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
1个月前
已完结
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial
1个月前
已完结
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial
1个月前
已完结
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
1个月前
已完结
Early Adjuvant Treatment with Semaglutide After Sleeve Gastrectomy in Patients with Class II-III Obesity: A Prospective Non-Randomized Controlled Study
1个月前
已完结
皖公网安备34019202002308
